Oriola Financial Statements From 2010 to 2024
| O5O Stock | EUR 0.90 0.04 4.65% |
Check Oriola Oyj financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oriola Oyj's main balance sheet or income statement drivers, such as , as well as many indicators such as . Oriola financial statements analysis is a perfect complement when working with Oriola Oyj Valuation or Volatility modules.
Oriola |
Oriola Oyj Company Return On Equity Analysis
Oriola Oyj's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Oriola Oyj Return On Equity | 0.0217 |
Most of Oriola Oyj's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oriola Oyj is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Oriola Oyj has a Return On Equity of 0.0217. This is 100.09% lower than that of the Healthcare sector and significantly higher than that of the Pharmaceutical Retailers industry. The return on equity for all Germany stocks is 107.0% lower than that of the firm.
Oriola Oyj Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Oriola Oyj's current stock value. Our valuation model uses many indicators to compare Oriola Oyj value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oriola Oyj competition to find correlations between indicators driving Oriola Oyj's intrinsic value. More Info.Oriola Oyj is regarded third in return on equity category among its peers. It also is regarded third in return on asset category among its peers reporting about 0.55 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Oriola Oyj is roughly 1.82 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oriola Oyj's earnings, one of the primary drivers of an investment's value.About Oriola Oyj Financial Statements
Oriola Oyj stakeholders use historical fundamental indicators, such as Oriola Oyj's revenue or net income, to determine how well the company is positioned to perform in the future. Although Oriola Oyj investors may analyze each financial statement separately, they are all interrelated. For example, changes in Oriola Oyj's assets and liabilities are reflected in the revenues and expenses on Oriola Oyj's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Oriola Oyj. Please read more on our technical analysis and fundamental analysis pages.
Oriola Oyj provides healthcare and wellbeing products in Sweden, Finland, and internationally.The company offers various range of OTC and traded good, vitamins, dietary supplements, pharmaceutical cosmetics, skincare products, tests, sports drinks, and wound care products. The company was formerly known as Oriola-KD Oyj and changed its name to Oriola Oyj in April 2017. ORIOLA OYJ operates under Pharmaceutical Retailers classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2768 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Oriola Stock
Oriola Oyj financial ratios help investors to determine whether Oriola Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oriola with respect to the benefits of owning Oriola Oyj security.